sleep apnea tirzepatide F.D.A. Approves Weight-Loss Drug to Treat FDA Approves First Sleep Apnea

De rol van incretinehormonen in metabolische processen

Semaglutide storage in context: comparing GLP-1 receptor agonist stability Semaglutide is not the only GLP-1 receptor agonist in widespread use, and comparing storage requirements across this drug class provides useful perspective

Results A total of 8184 individuals with obesity or overweight (and one or more weightrelated comorbidities) and without T2D initiated obesity pharmacotherapy with a prescription fill for injectable semaglutide or tirzepatide from January 1, 2022, to December 31, 2023

No obstante, los investigadores subrayan que se trata de datos preliminares y que ser necesario realizar estudios ms amplios

A Swedish registry (n = 12,277, 19802006) showed that RYGB was associated with a two-fold greater risk of inpatient AUD treatment than LAGB [281] and the controlled Swedish Obese Subjects study confirmed an elevated risk after gastric bypass [282]